신생아 케어 시장 : 제품 유형, 치료 영역, 용도, 유통 채널, 최종 사용자별 - 세계 시장 예측(2026-2032년)

The Neonatal Infant Care Market is projected to grow by USD 5.92 billion at a CAGR of 8.96% by 2032.

Neonatal infant care has moved from a specialized hospital service to a strategic pillar of maternal and child health, combining neonatal intensive care units, family-centered care, infection prevention, nutrition support, respiratory assistance, thermoregulation, monitoring, and post-discharge follow-up. Demand is shaped by the documented global burden of preterm birth, low birth weight, birth asphyxia, neonatal sepsis, congenital conditions, and complications during delivery.

The market is anchored by verified public health priorities. The World Health Organization reports that neonatal conditions remain a leading contributor to under-five mortality, while UNICEF and the UN Inter-agency Group for Child Mortality Estimation consistently show that the first 28 days of life carry the highest mortality risk for children. WHO also identifies complications of preterm birth, birth asphyxia or trauma, infections, and congenital anomalies as major causes of neonatal deaths. For hospitals and care networks, this creates a clear mandate: improve quality, expand access to neonatal intensive care, and build scalable systems that support early diagnosis, timely intervention, and safe transitions from NICU to home.

Transformative Shifts in Neonatal Infant Care

The neonatal infant care landscape is being reshaped by four major shifts: earlier risk identification, expansion of evidence-based newborn interventions, digitization of NICU operations, and stronger integration between maternal, neonatal, and pediatric care. The clinical focus is moving beyond survival alone toward neurodevelopmental outcomes, breastfeeding support, parental involvement, and long-term follow-up for preterm and medically fragile infants.

Hospitals are also reassessing capacity and staffing models as neonatal care becomes more technology-enabled. Continuous monitoring, noninvasive ventilation, incubator innovation, point-of-care diagnostics, human milk management, infection prevention, and antimicrobial stewardship are becoming core operating priorities. At the same time, global initiatives such as the Every Newborn Action Plan and Sustainable Development Goal targets for neonatal mortality are reinforcing investment in quality-of-care standards, workforce training, referral pathways, and equitable access to essential newborn care.

Cumulative Impact of Artificial Intelligence in Neonatal Care

Artificial intelligence is beginning to influence neonatal infant care through clinical decision support, predictive analytics, workflow automation, image interpretation, and remote monitoring. In NICU settings, AI-enabled models are being studied for earlier detection of sepsis, apnea, respiratory deterioration, feeding intolerance, retinopathy of prematurity risk, and abnormal vital sign patterns. These applications are most valuable when they support, not replace, specialist clinical judgment.

The cumulative impact of AI is expected to be strongest in high-volume NICUs and regional neonatal networks where real-time data from monitors, electronic health records, imaging systems, laboratory platforms, and bedside devices can be integrated. However, adoption depends on clinical validation, explainability, bias management, cybersecurity, regulatory compliance, and clinician trust. For providers, the near-term opportunity is to use AI to reduce alarm fatigue, prioritize high-risk infants, optimize staffing workflows, improve documentation, and standardize evidence-based interventions across neonatal intensive care and post-discharge follow-up.

Key Regional Insights for Neonatal Infant Care

Asia-Pacific represents one of the most consequential regions for neonatal infant care because of its large birth cohort, diverse health system maturity, and high-volume public health programs. Countries such as China, India, Japan, South Korea, and Australia are investing in neonatal intensive care capacity, digital health infrastructure, maternal-newborn referral systems, and quality improvement programs. Demand is especially strong for affordable incubators, phototherapy systems, respiratory support devices, newborn screening, infection prevention tools, and tele-neonatology models that can extend specialist guidance beyond major urban centers.

North America remains a mature, innovation-led neonatal care environment, with advanced NICU infrastructure, high adoption of monitoring and respiratory technologies, regionalized perinatal care, and established reimbursement pathways for complex newborn care. Europe benefits from structured perinatal networks, clinical guidelines, neonatal quality registries, and strong emphasis on patient safety, device compliance, and equitable outcomes. Latin America is expanding access through public hospital investments, newborn screening programs, and maternal-child health initiatives, with Brazil and Mexico playing central roles in care modernization. The Middle East is investing in tertiary care centers, specialist workforce development, and high-acuity neonatal services, while Africa continues to prioritize essential newborn care, Kangaroo Mother Care, infection control, oxygen access, safe delivery practices, and workforce development to reduce preventable neonatal deaths.

Key Group Insights Across Global Neonatal Care Markets

ASEAN markets are advancing neonatal care through maternal-child health modernization, expanding hospital networks, universal health coverage efforts, and growing adoption of affordable neonatal devices suited to high-volume public facilities. The GCC is characterized by high investment in tertiary hospitals, specialist workforce recruitment, digital hospital infrastructure, and premium neonatal intensive care capabilities, supported by national health transformation strategies and rising demand for complex newborn care.

The European Union emphasizes standardized quality, medical device regulation, cross-border clinical research, data protection, and equity in perinatal outcomes, creating a structured environment for neonatal technologies with clear evidence and safety profiles. BRICS economies combine large newborn populations with accelerating healthcare infrastructure investment, creating demand for scalable neonatal solutions across intensive care, essential newborn care, diagnostics, and monitoring. G7 countries continue to lead in NICU technology, clinical research, neonatal quality improvement, and evidence-based protocols, while NATO member countries benefit from strong health system resilience initiatives, medical logistics capability, and hospital modernization programs that can support neonatal emergency preparedness, transport, and continuity of care.

Key Country Insights for Neonatal Infant Care

The United States leads in advanced NICU services, neonatal subspecialty care, precision monitoring, neonatal transport, and payer-supported intensive care, while Canada emphasizes regionalized perinatal networks, public health coordination, and equitable access across large geographies. Mexico and Brazil are strengthening newborn screening, public hospital neonatal capacity, immunization-linked child health systems, and maternal-child health programs to reduce avoidable neonatal complications and improve early detection.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from structured perinatal systems, national clinical guidelines, neonatal professional networks, and strong uptake of respiratory, monitoring, thermoregulation, phototherapy, and nutrition solutions. Russia maintains demand for regional neonatal modernization, high-risk birth management, and specialist newborn care across geographically dispersed populations. In Asia-Pacific, China and India drive volume-led demand for scalable devices, NICU expansion, newborn screening, and telehealth-enabled referral support, Japan and South Korea emphasize advanced neonatal technology, quality outcomes, and low-noise, high-precision care environments, and Australia combines high clinical standards with telehealth-enabled access for rural and remote neonatal care.

Actionable Recommendations for Neonatal Care Leaders

Industry leaders should prioritize solutions that address the full neonatal care continuum, from antenatal risk stratification and delivery-room stabilization to NICU treatment, family education, and post-discharge monitoring. Product strategies should emphasize clinical validation, ease of use, interoperability, infection prevention, low-noise design, energy efficiency, alarm management, and adaptability across tertiary hospitals, district facilities, and resource-constrained settings.

Commercial teams should align offerings with measurable outcomes such as reduced hypothermia, improved oxygen targeting, earlier deterioration detection, lower hospital-acquired infection risk, safer medication and nutrition workflows, and stronger breastfeeding or human milk utilization. Partnerships with hospitals, ministries of health, academic neonatology centers, professional societies, and development agencies can accelerate adoption. Leaders should also invest in training, service networks, local manufacturing or assembly where appropriate, and regulatory evidence packages that meet both mature and emerging market requirements.

Research Methodology

This executive summary is developed through secondary research and expert synthesis using verified public health, clinical, regulatory, and industry sources. Core references include global health agencies, neonatal and pediatric associations, peer-reviewed clinical literature, national health statistics, regulatory guidance, hospital quality initiatives, and published information on neonatal devices, diagnostics, nutrition, respiratory support, and digital health technologies.

The methodology prioritizes triangulation across epidemiology, care delivery models, technology adoption, reimbursement dynamics, clinical guidelines, and regional health system maturity. Insights are assessed for relevance to neonatal intensive care, essential newborn care, preterm infant management, low birth weight care, respiratory support, thermoregulation, infection prevention, newborn screening, and post-discharge monitoring. Market interpretation excludes unsupported claims and focuses on documented trends, established clinical needs, and evidence-based interventions that influence procurement, investment, and strategic planning.

Conclusion

Neonatal infant care is entering a phase defined by precision monitoring, family-centered models, digital decision support, infection prevention, and expanded access to essential newborn interventions. The strongest opportunities are emerging where technology improves clinical workflow, supports earlier intervention, and strengthens continuity between maternal, neonatal, and pediatric care.

For healthcare providers and industry participants, the path forward requires balancing innovation with affordability, safety, interoperability, workforce readiness, and equity. Organizations that combine validated neonatal technologies with training, service support, and region-specific implementation strategies will be best positioned to improve outcomes for newborns while supporting sustainable development in the global neonatal infant care market.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Neonatal Infant Care Market, by Product Type

• 7.1. Infusion Pumps
  • 7.1.1. Syringe Pumps
  • 7.1.2. Volumetric Infusion Pumps
• 7.2. Neonatal Warmers
• 7.3. Phototherapy Devices
  • 7.3.1. Fiber Optic Phototherapy
  • 7.3.2. Fluorescent Phototherapy
  • 7.3.3. Light-Emitting Diode Phototherapy
• 7.4. Respiratory Care Devices
  • 7.4.1. Neonatal Ventilators
  • 7.4.2. Oxygen Hoods

8. Neonatal Infant Care Market, by Therapeutic Area

• 8.1. Hypothermia
• 8.2. Neonatal Abstinence Syndrome
• 8.3. Neonatal Jaundice
  • 8.3.1. Exchange Transfusion
  • 8.3.2. Phototherapy
• 8.4. Respiratory Distress Syndrome
  • 8.4.1. Surfactant Replacement
  • 8.4.2. Ventilation Support
• 8.5. Sepsis Management
  • 8.5.1. Antibiotic Delivery Systems
  • 8.5.2. Diagnostic Tools

9. Neonatal Infant Care Market, by Application

• 9.1. Intravenous Therapy
• 9.2. Jaundice Treatment
  • 9.2.1. Conventional Phototherapy
  • 9.2.2. Light-Emitting Diode Phototherapy
• 9.3. Monitoring
  • 9.3.1. Blood Gas Monitoring
  • 9.3.2. Vital Signs Monitoring
• 9.4. Respiratory Therapy
  • 9.4.1. Mechanical Ventilation
  • 9.4.2. Non-Invasive Ventilation
• 9.5. Temperature Management
  • 9.5.1. Active Warming
  • 9.5.2. Passive Warming

10. Neonatal Infant Care Market, by Distribution Channel

• 10.1. Online
  • 10.1.1. E-Commerce Platforms
  • 10.1.2. Manufacturer Websites
• 10.2. Offline

11. Neonatal Infant Care Market, by End User

• 11.1. Ambulatory Surgical Centers
• 11.2. Home Care Settings
• 11.3. Hospitals
• 11.4. Research Institutes
• 11.5. Specialty Clinics

12. Neonatal Infant Care Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Neonatal Infant Care Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Neonatal Infant Care Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Concentration Analysis, 2025
  • 15.1.1. Concentration Ratio (CR)
  • 15.1.2. Herfindahl Hirschman Index (HHI)
• 15.2. Recent Developments & Impact Analysis, 2025
• 15.3. Product Portfolio Analysis, 2025
• 15.4. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Ambu A/S
• 16.2. Analogic Corporation
• 16.3. Artsana S.p.A.
• 16.4. Cardinal Health, Inc.
• 16.5. CooperSurgical, Inc.
• 16.6. Dragerwerk AG & Co. KGaA
• 16.7. Embrace Innovations Pvt. Ltd.
• 16.8. Fanem Ltda.
• 16.9. GE HealthCare Technologies Inc.
• 16.10. Getinge AB
• 16.11. Heinen + Lowenstein GmbH & Co. KG
• 16.12. ICU Medical, Inc.
• 16.13. Inspiration Healthcare Group plc
• 16.14. Koninklijke Philips N.V.
• 16.15. Masimo Corporation
• 16.16. Medela AG
• 16.17. Medtronic plc
• 16.18. Mennen Medical Ltd.
• 16.19. Mindray Medical International Limited
• 16.20. Natus Medical Incorporated
• 16.21. Nice Neotech Medical Systems Pvt. Ltd.
• 16.22. Nihon Kohden Corporation
• 16.23. Utah Medical Products, Inc.